查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143472

輸血用具市場：全球市場預測，2026-2032年

Blood Administration Set Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，輸血用具市場規模將達到 181 億美元，複合年成長率為 8.87%。

主要市場統計數據
基準年 2025 99.8億美元
預計年份：2026年 106.8億美元
預測年份 2032 181億美元
複合年成長率 (%) 8.87%

輸血包：概述

輸血器是無菌的一次性醫療設備，旨在支持血液和血液成分的控制性輸注。其性能取決於可靠的流路、過濾能力、與輸血設備的兼容性、安全的連接以及清晰的識別資訊。醫院的輸血活動、外科手術、創傷急救、腫瘤治療、婦幼保健和感染預防等需求是推動輸血器市場發展的因素。因此，該市場與醫療服務能力、血庫運作、採購標準以及臨床供應鏈的品質密切相關。

安全、標準化和供應鏈韌性正在改變產業格局。

產業趨勢正朝著更加重視病患安全、可追溯性、互通性和產品品質一致性的方向發展。醫療專業人員在評估輸血器時，擴大考慮一系列綜合因素，包括過濾性能、防漏性能、預充便捷性、與輸血泵和接頭的兼容性、包裝完整性以及工作流程效率。監管機構的監督和醫院規程也進一步提升了檢驗的生產流程、無菌屏障、批次級可追溯性和上市後監測記錄的重要性。

人工智慧 (AI) 可以改善需求預測、品管和輸血工作流程。

人工智慧可以透過改善輸血用品需求判斷系統，間接影響輸血流程的運作。預測分析可以整合治療方案、血液使用情況、庫存記錄、季節性需求和緊急應變狀態等信息，從而支持補貨計劃，減少不必要的斷貨和庫存積壓。在醫院，決策支援工具還可以幫助調整血庫的工作流程、設備可用性和文件要求。

區域洞察：不同的監管環境和醫療服務重點

在北美，重點在於嚴格的品管系統、醫院標準化、可追溯性以及與先進血庫和手術流程的整合。在歐洲，則高度重視監管要求的協調統一、病人安全、永續性考量以及公共醫療體系內採購系統的一致性。在亞太地區，先進的醫院市場與快速擴張的醫療服務能力並存，由此產生了對經濟實惠、區域適應性強且可擴展的輸血基礎設施的多樣化需求。

集團特定見解：採購和監管協調因區域集團而異。

在東協市場，由於各市場監管成熟度、醫療基礎設施和本地製造能力存在差異，靈活的合規和分銷策略至關重要。金磚國家成員國擁有大規模的醫療體系，但監管路徑、國內產業政策和公共採購結構各不相同。因此，供應商必須謹慎，切勿想當然地採用單一的區域營運模式。雖然歐盟受益於監管協調和跨境標準，但各國採購慣例和醫院要求仍會影響實施。

國別洞察：本地系統影響產品需求

在澳洲和加拿大，基於監管的採購、地域覆蓋廣泛的配送體係以及可靠的醫院供貨是關鍵考慮因素。在巴西和墨西哥，公立和私立醫療保健體系的多樣化需求，以及當地的報名手續、複雜的採購流程和龐大的分銷網路，都會影響產品的供應。中國面臨醫院需求大規模、國內醫療設備規模、預算和輸血量等各個方面。

給經營團隊的建議：將安全、韌性和證據納入你們的策略。

產業領導者必須先確保產品開發與檢驗的臨床和營運需求相符。具體而言，這些需求包括可靠的過濾、安全的連接、直覺的操作、包裝的完整性以及與常用輸血設備的兼容性。品管系統應包括嚴格的供應商認證、檢驗的滅菌流程、批次追溯、申訴分析以及關鍵零件的緊急時應對計畫。在產品上市前，應充分了解區域監管要求，而不是將其視為開發完成後才考慮的問題。

調查方法：基於證據的市場估值框架

本執行摘要基於對輸血器械市場的定義以及必要的區域和群體特定觀點。評估內容包括醫療設備功能、輸血流程、監管和品質預期、醫療基礎設施、採購行為、供應鏈韌性以及人工智慧在營運中的潛在作用。區域、群體和國家的具體觀察以定性比較而非數值市場預測的形式呈現。

結論：可靠的醫療設備需要可靠的系統。

輸血用具在輸血安全中發揮著至關重要的作用，它將無菌產品設計、血庫管理、臨床技術和醫院物流緊密聯繫起來。最具永續的改進途徑在於將穩定的醫療設備性能與更強大的可追溯性、完善的採購系統、檢驗的數位化工具以及有效的人力資源開發相結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：輸血器市場：依產品類型分類

  • 封閉式系統
  • 開放系統

第8章：輸血器市場：依材料分類

  • 不含聚氯乙烯
    • EVA
    • 聚乙烯
  • PVC

第9章：輸血器市場：依流速分類

  • 高流速
  • 低流量
  • 中等流速

第10章：輸血器市場：依觸發機制分類

  • 電子設備
  • 重力型

第11章：輸血器市場：依最終用戶分類

  • 門診治療
  • 診所
  • 醫院

第12章：輸血器市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：輸血器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 輸血器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Coloplast A/S
  • Fresenius Kabi AG
  • Grifols, SA
  • Haemonetics Corporation
  • ICU Medical, Inc.
  • McKesson Medical-Surgical Inc.
  • Medtronic plc
  • Mercury Medical LLC
  • Molnlycke Health Care AB
  • Nipro Corporation
  • Pfizer Inc.
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Unomedical by ConvaTec Group
  • Vyaire Medical, Inc.
  • Vygon SA

第17章 主要專家

Product Code: MRR-9C4233EE7CE7

The Blood Administration Set Market is projected to grow by USD 18.10 billion at a CAGR of 8.87% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.98 billion
Estimated Year [2026] USD 10.68 billion
Forecast Year [2032] USD 18.10 billion
CAGR (%) 8.87%

Blood Administration Sets: Executive Overview

Blood administration sets are sterile, single-use devices designed to support the controlled transfusion of blood and blood components. Their performance depends on reliable fluid pathways, filtration, compatibility with transfusion equipment, secure connections, and clear identification. Demand is shaped by transfusion activity, surgical care, trauma response, oncology, maternal health, and hospital infection-prevention requirements. The market is therefore closely connected to healthcare capacity, blood-bank operations, procurement standards, and the quality of clinical supply chains.

Safety, Standardization, and Supply Resilience Are Reshaping the Landscape

The landscape is shifting toward stronger emphasis on patient safety, traceability, interoperability, and consistent product quality. Healthcare providers increasingly evaluate sets through the combined lens of filtration performance, leakage prevention, ease of priming, compatibility with pumps and connectors, packaging integrity, and workflow efficiency. Regulatory scrutiny and hospital protocols are also reinforcing the importance of validated manufacturing, sterile barriers, lot-level traceability, and documented post-market surveillance.

Procurement priorities are evolving alongside supply-chain lessons from recent disruptions. Hospitals and blood services are placing greater value on qualified secondary sources, regional inventory visibility, standardized product specifications, and continuity planning. Sustainability is also becoming more relevant, although infection-control requirements mean that material changes must be assessed carefully against sterility, performance, and disposal obligations.

Artificial Intelligence Improves Forecasting, Quality Control, and Transfusion Workflows

Artificial intelligence can influence blood administration set operations indirectly by improving the systems that determine when, where, and how transfusion supplies are needed. Predictive analytics can combine procedure schedules, blood utilization, inventory records, seasonal demand, and emergency activity to support replenishment planning and reduce avoidable shortages or excess stock. In hospitals, decision-support tools may also help coordinate blood-bank workflows, equipment availability, and documentation requirements.

Manufacturing applications include computer-vision inspection for packaging defects, tubing anomalies, connector quality, and particulate concerns, as well as analytics for process monitoring and maintenance. These tools should remain subject to validation, cybersecurity controls, human oversight, and applicable medical-device requirements. AI can strengthen consistency and visibility, but it does not replace clinical judgment, sterile manufacturing controls, or established transfusion protocols.

Regional Insights: Diverse Regulatory and Care-Delivery Priorities

North America emphasizes stringent quality systems, hospital standardization, traceability, and integration with sophisticated blood-bank and surgical workflows. Europe places strong weight on harmonized regulatory expectations, patient safety, sustainability considerations, and procurement alignment across public healthcare systems. Asia-Pacific combines advanced hospital markets with rapidly expanding healthcare capacity, creating varied needs for affordability, local supply resilience, and scalable transfusion infrastructure.

Latin America is influenced by uneven healthcare access, public procurement cycles, and the need for dependable products across centralized and decentralized services. The Middle East is shaped by investments in specialized hospitals, emergency preparedness, and imported medical-device supply chains, while the GCC generally benefits from coordinated healthcare development. Africa presents a strong need for robust, accessible transfusion infrastructure, dependable distribution, appropriate storage and handling practices, and products suited to resource-constrained settings. Across all regions, training and blood-safety systems are as important as device specifications.

Group Insights: Procurement and Regulatory Alignment Vary by Bloc

ASEAN markets reflect differing levels of regulatory maturity, healthcare infrastructure, and local manufacturing capability, making adaptable compliance and distribution strategies important. BRICS members combine major healthcare systems with distinct regulatory pathways, domestic-industry policies, and public procurement structures; suppliers must therefore avoid assuming a single regional operating model. The European Union benefits from regulatory coordination and cross-border standards, while national purchasing practices and hospital requirements still influence adoption.

The G7 generally places substantial emphasis on evidence, quality management, infection prevention, sustainability, and supply continuity. GCC healthcare systems often prioritize advanced clinical capacity, centralized purchasing, and dependable international logistics. NATO countries are not a single medical-device market, but shared concerns around emergency preparedness, interoperability, and resilient medical supply chains can affect institutional planning. Across these groups, compliance mapping and local stakeholder engagement remain essential.

Country Insights: Local Systems Shape Product Requirements

Australia and Canada emphasize regulated procurement, geographically resilient distribution, and reliable hospital supply. Brazil and Mexico face diverse public and private healthcare requirements, with local registration, procurement complexity, and distribution reach influencing access. China combines large-scale hospital demand with evolving domestic-device capabilities and regulatory expectations, while India requires solutions that can serve highly varied facility sizes, budgets, and transfusion workloads.

France, Germany, Italy, Spain, and the United Kingdom place strong emphasis on quality assurance, clinical governance, and public-sector purchasing processes, with differences in national implementation and reimbursement environments. Japan and South Korea are characterized by advanced hospital infrastructure, exacting quality expectations, and interest in efficient, dependable workflows. Russia's healthcare-device environment is affected by regulatory, procurement, and supply-chain conditions. In the United States, hospital networks, blood centers, accreditation requirements, and evidence-based purchasing strongly influence product selection.

Actions for Leaders: Build Safety, Resilience, and Evidence Into Strategy

Industry leaders should first align product development with verified clinical and operational needs: dependable filtration, secure connections, intuitive handling, packaging integrity, and compatibility with commonly used transfusion equipment. Quality systems should include robust supplier qualification, validated sterilization, lot traceability, complaint analysis, and contingency plans for critical components. Regional regulatory requirements should be mapped before launch rather than treated as a post-development activity.

Commercial and operational strategies should pair reliable distribution with customer education for blood banks, nurses, procurement teams, and biomedical staff. Leaders should use demand and inventory analytics responsibly, establish measurable service-level indicators, and assess sustainability claims through lifecycle evidence. Partnerships with healthcare institutions can support workflow validation, while transparent post-market monitoring can strengthen trust and identify improvement opportunities without overstating clinical benefits.

Research Methodology: Evidence-Based Market Assessment Framework

This executive summary is structured around the supplied market definition for blood administration sets and the required geographic and group lenses. The assessment considers device function, transfusion workflows, regulatory and quality expectations, healthcare infrastructure, procurement behavior, supply-chain resilience, and the potential operational role of artificial intelligence. Regional, group, and country observations are framed as qualitative comparisons rather than numerical market claims.

A rigorous full study would triangulate official regulatory publications, standards, hospital and blood-service guidance, peer-reviewed clinical and engineering literature, procurement documentation, manufacturer quality information, and interviews with qualified healthcare stakeholders. Findings should be cross-checked for publication date, jurisdiction, methodological quality, and applicability to blood administration sets. No market estimates, market shares, forecasts, or company-specific claims are used here.

Conclusion: Reliable Devices Must Be Matched With Reliable Systems

Blood administration sets occupy a critical position in transfusion safety, connecting sterile product design with blood-bank controls, clinical technique, and hospital logistics. The most durable opportunities for improvement are likely to come from combining consistent device performance with stronger traceability, resilient sourcing, validated digital tools, and effective workforce training.

Regional and country conditions differ substantially, but the central priorities are consistent: protect patients, maintain sterility, support dependable workflows, comply with applicable requirements, and ensure availability when transfusion is needed. Leaders that treat the product as part of an integrated transfusion system-not as an isolated consumable-will be better positioned to improve safety, efficiency, and operational continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blood Administration Set Market, by Product Type

  • 7.1. Introduction
  • 7.2. Closed System
  • 7.3. Open System

8. Blood Administration Set Market, by Material

  • 8.1. Introduction
  • 8.2. Non-PVC
    • 8.2.1. EVA
    • 8.2.2. Polyethylene
  • 8.3. PVC

9. Blood Administration Set Market, by Flow Rate

  • 9.1. Introduction
  • 9.2. High Flow
  • 9.3. Low Flow
  • 9.4. Medium Flow

10. Blood Administration Set Market, by Trigger Mechanism

  • 10.1. Introduction
  • 10.2. Electronic
  • 10.3. Gravity

11. Blood Administration Set Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care
  • 11.3. Clinic
  • 11.4. Hospital

12. Blood Administration Set Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Blood Administration Set Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Blood Administration Set Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Argon Medical Devices, Inc.
  • 16.2. B. Braun Melsungen AG
  • 16.3. Baxter International Inc.
  • 16.4. Becton, Dickinson and Company
  • 16.5. Cardinal Health, Inc.
  • 16.6. Coloplast A/S
  • 16.7. Fresenius Kabi AG
  • 16.8. Grifols, S.A.
  • 16.9. Haemonetics Corporation
  • 16.10. ICU Medical, Inc.
  • 16.11. McKesson Medical-Surgical Inc.
  • 16.12. Medtronic plc
  • 16.13. Mercury Medical LLC
  • 16.14. Molnlycke Health Care AB
  • 16.15. Nipro Corporation
  • 16.16. Pfizer Inc.
  • 16.17. Smiths Medical, Inc.
  • 16.18. Teleflex Incorporated
  • 16.19. Terumo Corporation
  • 16.20. Unomedical by ConvaTec Group
  • 16.21. Vyaire Medical, Inc.
  • 16.22. Vygon SA

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Blood Administration Set Market, Years Considered for the Study
  • FIGURE 2. Global Blood Administration Set Market, Research Design
  • FIGURE 3. Global Blood Administration Set Market, Research Framework
  • FIGURE 4. Global Blood Administration Set Market, Data Triangulation
  • FIGURE 5. Global Blood Administration Set Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Blood Administration Set Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Blood Administration Set Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Blood Administration Set Market Size, by Material, 2025 vs 2032 (%)
  • FIGURE 9. Global Blood Administration Set Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Blood Administration Set Market Size, by Flow Rate, 2025 vs 2032 (%)
  • FIGURE 11. Global Blood Administration Set Market Size, by Flow Rate, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Blood Administration Set Market Size, by Trigger Mechanism, 2025 vs 2032 (%)
  • FIGURE 13. Global Blood Administration Set Market Size, by Trigger Mechanism, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Blood Administration Set Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Blood Administration Set Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Blood Administration Set Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Blood Administration Set Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Blood Administration Set Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Blood Administration Set Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Blood Administration Set Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Blood Administration Set Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Blood Administration Set Market Segmentation & Coverage
  • TABLE 2. Global Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Closed System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Closed System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Closed System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Open System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Open System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Open System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 11. Global Non-PVC Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Non-PVC Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Non-PVC Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global EVA Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global EVA Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global EVA Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Polyethylene Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Polyethylene Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Polyethylene Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global PVC Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global PVC Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global PVC Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 24. Global High Flow Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global High Flow Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global High Flow Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Low Flow Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Low Flow Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Low Flow Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Medium Flow Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Medium Flow Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Medium Flow Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 34. Global Electronic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Electronic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Electronic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Gravity Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Gravity Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Gravity Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 41. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Asia-Pacific Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Asia-Pacific Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 53. Asia-Pacific Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 54. Asia-Pacific Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 55. Asia-Pacific Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 56. Asia-Pacific Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 57. Asia-Pacific Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 58. North America Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. North America Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 60. North America Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 61. North America Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 62. North America Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 63. North America Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 64. North America Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 65. Latin America Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Latin America Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 67. Latin America Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 68. Latin America Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 69. Latin America Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 70. Latin America Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 71. Latin America Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 72. Europe Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Europe Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 74. Europe Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 75. Europe Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 76. Europe Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 77. Europe Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 78. Europe Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 79. Middle East Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Middle East Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 81. Middle East Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 82. Middle East Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 83. Middle East Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 84. Middle East Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 85. Middle East Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 86. Africa Blood Administration Set Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Africa Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 88. Africa Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 89. Africa Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 90. Africa Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 91. Africa Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 92. Africa Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 93. Global Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. ASEAN Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. ASEAN Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 96. ASEAN Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 97. ASEAN Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 98. ASEAN Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 99. ASEAN Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 100. ASEAN Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 101. GCC Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. GCC Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 103. GCC Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 104. GCC Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 105. GCC Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 106. GCC Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 107. GCC Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 108. European Union Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 109. European Union Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 110. European Union Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 111. European Union Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 112. European Union Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 113. European Union Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 114. European Union Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 115. BRICS Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 116. BRICS Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 117. BRICS Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 118. BRICS Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 119. BRICS Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 120. BRICS Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 121. BRICS Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 122. G7 Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 123. G7 Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 124. G7 Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 125. G7 Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 126. G7 Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 127. G7 Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 128. G7 Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 129. NATO Blood Administration Set Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 130. NATO Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 131. NATO Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 132. NATO Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 133. NATO Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 134. NATO Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 135. NATO Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 136. Global Blood Administration Set Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. United States Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 138. United States Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 139. United States Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 140. United States Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 141. United States Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 142. United States Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 143. United States Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 144. Canada Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 145. Canada Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 146. Canada Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 147. Canada Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 148. Canada Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 149. Canada Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 150. Canada Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 151. Mexico Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 152. Mexico Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 153. Mexico Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 154. Mexico Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 155. Mexico Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 156. Mexico Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 157. Mexico Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 158. Brazil Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 159. Brazil Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 160. Brazil Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 161. Brazil Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 162. Brazil Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 163. Brazil Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 164. Brazil Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. United Kingdom Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 166. United Kingdom Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 167. United Kingdom Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 168. United Kingdom Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 169. United Kingdom Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 170. United Kingdom Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 171. United Kingdom Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. Germany Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 173. Germany Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 174. Germany Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 175. Germany Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 176. Germany Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 177. Germany Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 178. Germany Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 179. France Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 180. France Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 181. France Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 182. France Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 183. France Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 184. France Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 185. France Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 186. Russia Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 187. Russia Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 188. Russia Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 189. Russia Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 190. Russia Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 191. Russia Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 192. Russia Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 193. Italy Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 194. Italy Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 195. Italy Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 196. Italy Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 197. Italy Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 198. Italy Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 199. Italy Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 200. Spain Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 201. Spain Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 202. Spain Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 203. Spain Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 204. Spain Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 205. Spain Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 206. Spain Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 207. China Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 208. China Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 209. China Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 210. China Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 211. China Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 212. China Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 213. China Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 214. India Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 215. India Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 216. India Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 217. India Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 218. India Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 219. India Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 220. India Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. Japan Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 222. Japan Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 223. Japan Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 224. Japan Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 225. Japan Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 226. Japan Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 227. Japan Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 228. Australia Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 229. Australia Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 230. Australia Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 231. Australia Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 232. Australia Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 233. Australia Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 234. Australia Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 235. South Korea Blood Administration Set Market Size, 2017-2032 (USD Million)
  • TABLE 236. South Korea Blood Administration Set Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 237. South Korea Blood Administration Set Market Size, by Material, 2017-2032 (USD Million)
  • TABLE 238. South Korea Blood Administration Set Market Size, by Non-PVC, 2017-2032 (USD Million)
  • TABLE 239. South Korea Blood Administration Set Market Size, by Flow Rate, 2017-2032 (USD Million)
  • TABLE 240. South Korea Blood Administration Set Market Size, by Trigger Mechanism, 2017-2032 (USD Million)
  • TABLE 241. South Korea Blood Administration Set Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 242. Global Blood Administration Set Market Share, by Key Player, 2025
  • TABLE 243. Global Blood Administration Set Market, Key Experts